lung cancer treatment options Archives - Page 2 of 2

Ask the Experts: Clinical Trials for KRAS+ Lung Cancer

Question: I have KRAS+ lung cancer. Are there any clinical trials available for me? Answer: Yes! No matter what kind of lung cancer you are diagnosed with, there is likely a trial appropriate for you. GO2 for Lung Cancer [...]

FDA Approves Libtayo in Combination with Chemotherapy for Patients with NSCLC Regardless of PD-L1 Status

Bethany Johnson (GO2 for Lung Cancer)2022-11-09T14:53:16-06:00November 9th, 2022|Hot Topics, News, Science and Research|

On November 8th, 2022, the Food and Drug Administration (FDA) approved Libtayo (cemiplimab-rwlc) for treatment of non-small cell lung cancer where there are no changes in ALK, EGFR or ROS1 in combination with platinum doublet chemotherapy. The FDA based [...]